Evidence map›Paper›PMID 34764092›Full record

ArticleBMJ case reports2021

Measuring antibody titres following rabies postexposure prophylaxis in immunosuppressed patients: a norm rather than the exception.

Ritin Mohindra, Vikas Suri, Debajyoti Chatterjee, Kirtan Rana

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Fatal Human Rabies Infection With Suspected Host-Mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ritin MohindraInternal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Vikas SuriInternal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Debajyoti ChatterjeeHistopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Kirtan RanaCommunity Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India ranakirtan006@gmail.com.ORCID http://orcid.org/0000-0001-9862-5700
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of a 51-year-old immunosuppressed man with underlying chronic lymphoproliferative leukaemia (CLL), who presented to us in emergency with breathlessness, hydrophobia, anxiety and restlessness. He had a history of category 3 dog bite 2 months ago and had received a full course of rabies immunoglobulin and antirabies vaccine (ARV) as per the national schedule. As there were frank clinical reports of rabies, the patient was managed according to Milwaukee regimen. The patients died within a week of the appearance of symptoms. The brain autopsy revealed Negri bodies conforming the mortality due to rabies.Immunosuppressed patients, like our patient who had CLL have low antibody formation after rabies prophylaxis. Antibody titres in immunosuppressed patients need to be measured after the 2-4 weeks of the last injection of ARV to decide whether a booster of ARV needs to be administered or not.

Indexed as

Bites and StingsRabiesRabies VaccinesAnimalsAntibody FormationDogsHumansMalePost-Exposure ProphylaxisRabies Vaccinesemergency medicinepublic health

Identifiers

PMID34764092
PMCPMC8587606
OpenAlexW3213019021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.